CORRECTING and REPLACING BASi Introduces the Next Generation of Electrochemical Analyzer With the Release of the Epsilon EClipse™

BASi introduces Epsilon EClipse™ as the newest addition to its industry-leading Electrochemical Analyzer family of instrumentation. (Photo: Business Wire)

CORRECTION...by Bioanalytical Systems, Inc.

WEST LAFAYETTE, Ind.--()--Fourth paragraph, first sentence should read: The Epsilon EClipse™ with vastly improved user friendliness includes a modern Windows® interface, allows for opening an unlimited number of files and will be easier to view and select a variety of plots (instead of The Epsilon EClipse™ with vastly improved user friendliness includes a modern Windows® interface, it allows for opening an unlimited of files and it will be easier to view and select a variety of plots.)

The corrected release reads:

Bioanalytical Systems, Inc. (BASi) (NASDAQ:BASI), a leader in the development of instrumentation for bioanalytical separations and quantitative electroanalytical measurements is proud to introduce the Epsilon EClipse™ as the newest addition to its industry-leading Electrochemical Analyzer family of instrumentation.

“With the introduction of the BASi Epsilon over three decades ago, the BASi name has become synonymous with electroanalytical innovation, reliability, and meticulous design allowing for precise quantitative and qualitative electrochemical characterization... The new Epsilon EClipse™ builds on this legacy and will enable scientific researchers to continue conducting cutting edge research and development,” said Jacqueline Lemke, President and CEO of BASi. “With this new product, we are excited to provide our customers with enhanced software, improved technique sequences and an increased applied potential range. Our full line of electrochemistry products includes state-of-the-art electronic instrumentation, as well as guaranteed high-quality accessories, including a large selection of electrodes and complete cell packages.”

The Epsilon EClipse™ builds on the success of the Epsilon product family and makes BASi’s trusted electrochemical analyzer technology accessible to all laboratories interested in more streamlined and user friendly instrumentation. The more user friendly interface includes an easy access front connector, and the Epsilon EClipse™ offers an increased applied potential range from ±3.275V to ±10V.

The Epsilon EClipse™ with vastly improved user friendliness includes a modern Windows® interface, allows for opening an unlimited number of files and will be easier to view and select a variety of plots. New and improved technique notes are also available.

The new platform is backward compatible with all existing techniques and data files in the Epsilon software. The unit is available as either standard or bi-potentiostat and is compatible with all existing BASi cell stands. Orders are being taken now for delivery in April.

For technical guidance and expertise, please call the BASi Electrochemical Product Manager, James Hill, PhD at 765-497-5859.

About Bioanalytical Systems, Inc.

BASi is a pharmaceutical development company providing contract research services and monitoring instruments to the world's leading drug development companies and medical research organizations. BASi focuses on developing innovative services and products that increase efficiency and reduce the cost of taking new drugs to market. Visit www.BASinc.com for more information about BASi.

Contacts

Bioanalytical Systems, Inc.
Jeffrey Potrzebowski, 765-497-8409
Chief Financial Officer
jpotrzebowski@BASinc.com

Release Summary

BASi Introduces the Next Generation of Electrochemical Analyzer With the Release of the Epsilon EClipse™

Contacts

Bioanalytical Systems, Inc.
Jeffrey Potrzebowski, 765-497-8409
Chief Financial Officer
jpotrzebowski@BASinc.com